ID: ALA175119

Max Phase: Preclinical

Molecular Formula: C24H25ClN2O4

Molecular Weight: 440.93

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCC(CC)(CC(=O)Nc1cccc(OCc2ccc3ccc(Cl)cc3n2)c1)C(=O)O

Standard InChI:  InChI=1S/C24H25ClN2O4/c1-3-24(4-2,23(29)30)14-22(28)27-18-6-5-7-20(13-18)31-15-19-11-9-16-8-10-17(25)12-21(16)26-19/h5-13H,3-4,14-15H2,1-2H3,(H,27,28)(H,29,30)

Standard InChI Key:  NONOYDRCZAMJOK-UHFFFAOYSA-N

Associated Targets(Human)

Cysteinyl leukotriene receptor 1147 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Cysteinyl leukotriene receptor 1 781 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Cavia porcellus 23802 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 440.93Molecular Weight (Monoisotopic): 440.1503AlogP: 5.69#Rotatable Bonds: 9
Polar Surface Area: 88.52Molecular Species: ACIDHBA: 4HBD: 2
#RO5 Violations: 1HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: 4.06CX Basic pKa: 2.29CX LogP: 5.32CX LogD: 2.31
Aromatic Rings: 3Heavy Atoms: 31QED Weighted: 0.45Np Likeness Score: -1.33

References

1. von Sprecher A, Gerspacher M, Beck A, Kimmel S, Wiestner H, Anderson GP, Niederhauser U, Subramanian N, Bray MA..  (1998)  Synthesis and SAR of a novel, potent and structurally simple LTD4 antagonist of the quinoline class.,  (8): [PMID:9871521] [10.1016/s0960-894x(98)00137-1]

Source